Authors: Miller, V Cozzi-Lepri, A Hertogs, K Gute, P Larder, B Bloor, S Klauke, S Rabenau, H Phillips, A Staszewski, S

Citation: V. Miller et al., HIV drug susceptibility and treatment response to mega-HAART regimen in patients from the Frankfurt HIV cohort, ANTIVIR TH, 5(1), 2000, pp. 49-55

Authors: Miller, V Sabin, C Hertogs, K Bloor, S Martinez-Picado, J D'Aquila, R Larder, B Lutz, T Gute, P Weidmann, E Rabenau, H Phillips, A Staszewski, S

Citation: V. Miller et al., Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure, AIDS, 14(18), 2000, pp. 2857-2867

Authors: Staszewski, S Miller, V Sabin, C Schlecht, C Gute, P Stamm, S Leder, T Berger, A Weidemann, E Hill, A Phillips, A

Citation: S. Staszewski et al., Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy, AIDS, 13(8), 1999, pp. 951-956

Authors: Staszewski, S Haberl, A Gute, P Nisius, G Miller, V Carlebach, A

Citation: S. Staszewski et al., Nevirapine/didanosine/lamivudine once daily in HIV-1-infected intravenous drug users, ANTIVIR TH, 3, 1998, pp. 55-56